Skip to main content
Premium Trial:

Request an Annual Quote

Readers Rank RNA Interference Technology


Pattern Recognition
Stats, Rankings & Facts

Readers Rank RNA Interference Technology

Taken from GenomeWeb’s 2003 RNAi Technology Usage Market Snapshot survey results, the following lists show how Genome Technology and GenomeWeb Daily News subscribers rate the vendors of synthesized short interfering RNAi oligos and tools for designing siRNAs.


Best-known siRNA vendors

1. (tie) Ambion and Qiagen

2. Dharmacon

3. Sequitur

4. Proligo


Vendors patronized most by those who have bought siRNAs

1. Dharmacon

2. Qiagen

3. Ambion

4. Proligo

5. Sequitur


Best-known siRNA design tools

1. Ambion’s siRNA Target Finder

2. Dharmacon siDesign Center

3. Qiagen’s siRNA Design & Ordering Page

4. Tuschl’s siRNA User’s Guide

5. Whitehead Institute’s siRNA Program


Design tools most used by those who have designed siRNAs

1. Tuschl’s siRNA User’s Guide

2. (3-way tie) Ambion’s siRNA Target Finder
Dharmacon siDesign Center
Qiagen’s siRNA Design & Ordering Page

3. Whitehead Institute’s siRNA Program


To obtain a complete copy of GenomeWeb’s 2003 RNAi Technology Usage Market Snapshot report, visit


The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.